☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Select OTC
Takeda to Divest a Portfolio of Select OTC and Non-Core Assets to Hypera Pharma in Latin America for $825M
March 2, 2020
Takeda to Divest its Portfolio of Select OTC and Non-Core Assets to Acino for ~$200M in NEMEA Countries
October 15, 2019
Load more...
Back to Home